Abstract
Background: Nowadays, patients involved in antiplatelet therapy required special attention during oral surgery procedures, due to the antiplatelet drugs assumption. The motivations of the assumption may be different and related to the patient’s different systemic condition. For this reason, accordingly to the current international guidelines, different protocols can be followed. The aim of this work is to analyze how the dentist’s approach to these patients has changed from the past to the present, evaluating the risk exposure for the patients. Methods: This review paper considered different published papers in literature through quoted scientific channels, going in search of “ancient” works in such a way as to highlight the differences in the protocols undertaken. The analyzed manuscripts are in the English language, taking into consideration reviews, case reports, and case series in such a way as to extrapolate a sufficient amount of data and for evaluating the past therapeutic approaches compared to those of today. Results: Colleagues in the past preferred to subject patients to substitution therapy with low molecular weight anticoagulants, by suspending antiplatelet agents to treatment patients, often for an arbitrary number of days. The new guidelines clarify everything, without highlighting an increased risk of bleeding during simple oral surgery in patients undergoing antiplatelet therapy. Conclusion: Either patients take these medications for different reasons, because of cardiovascular pathologies, recent cardiovascular events, or even for simple prevention, although the latest research shows that there is no decrease of cardiovascular accidents in patients who carry out preventive therapy. Surely, it will be at the expense of the doctor to assess the patient’s situation and risk according to the guidelines. For simple oral surgery, it is not necessary to stop therapy with antiplatelet agents because the risk of bleeding has not increased, and is localized to a post-extraction alveolus or to an implant preparation, compared to patients who do not carry out this therapy. From an analysis of the results it emerges that the substitutive therapy should no longer be performed and that it is possible to perform oral surgery safely in patients who take antiplatelet drugs, after a thorough medical history. Furthermore, by suspending therapy, we expose our patients to more serious risks, concerning their main pathology, where present.
Highlights
For the dentist, the evaluation of the patient with systemic diseases tends to a summary diagnosisFor the dentist, the evaluation of the patient with systemic diseases tends to a summary that has the function of reducing the risk of complications caused by dental intervention and to plan diagnosis that has the function of reducing the risk of complications caused by dental intervention an appropriate therapy to the general condition of the patient
The evaluation of the patient with systemic diseases tends to a summary that has the function of reducing the risk of complications caused by dental intervention and to plan diagnosis that has the function of reducing the risk of complications caused by dental intervention an appropriate therapy to the general condition of the patient
Many patients are treated with antiplatelet drugs nowadays, as practices for surgical treatment typical past approach was to suspend the therapy and to carry many go to the dental practices for surgical treatment [1]
Summary
The evaluation of the patient with systemic diseases tends to a summary that has the function of reducing the risk of complications caused by dental intervention and to plan diagnosis that has the function of reducing the risk of complications caused by dental intervention an appropriate therapy to the general condition of the patient. Conclusion: Either patients take these medications for different reasons, because of cardiovascular pathologies, recent cardiovascular events, or even for simple prevention, the latest research shows that there is no decrease of cardiovascular accidents in patients who carry out preventive therapy It will be at the expense of the doctor to assess the patient’s situation and risk according to the guidelines. It is not necessary to stop therapy with antiplatelet agents because the risk of bleeding has not increased, and is localized to a post-extraction alveolus or to an implant preparation, compared to patients who do not carry out this therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have